Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Antipsychotics are the mainstay in schizophrenia management, and long-acting injectable (LAI) antipsychotics contribute to the successful maintenance of treatment by improving non-adherence and preventing relapses. Paliperidone palmitate 3-monthly (PP3M) formulation is the only available LAI antipsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathews, Maju, Gopal, Srihari, Nuamah, Isaac, Hargarter, Ludger, Savitz, Adam J, Kim, Edward, Tan, Wilson, Soares, Bernardo, Correll, Christoph U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535080/
https://www.ncbi.nlm.nih.gov/pubmed/31190840
http://dx.doi.org/10.2147/NDT.S197225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535080/
https://www.ncbi.nlm.nih.gov/pubmed/31190840
http://dx.doi.org/10.2147/NDT.S197225

Ejemplares similares